Cargando…
Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma
BACKGROUND: The aim of the current study was to construct prognostic nomograms for individual risk prediction in elderly patients with osteosarcoma. METHODS: Data for 816 elderly patients (≥40 years old) with osteosarcoma between 2004 and 2016 from the Surveillance, Epidemiology, and End Results (SE...
Autores principales: | Liu, Xiaoqiang, He, Shaoya, Yao, Xi, Hu, Tianyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449646/ https://www.ncbi.nlm.nih.gov/pubmed/34548809 http://dx.doi.org/10.2147/IJGM.S331623 |
Ejemplares similares
-
Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo
por: Liu, Xiaoqiang, et al.
Publicado: (2019) -
Development and Validation of Prognostic Nomogram for Elderly Breast Cancer: A Large-Cohort Retrospective Study
por: Li, Gangfeng, et al.
Publicado: (2022) -
Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer
por: Tian, Shengwei, et al.
Publicado: (2021) -
Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms
por: Xu, Ruitong, et al.
Publicado: (2021) -
Development and external validation of a prognostic nomogram for patients with gastric cancer after radical gastrectomy
por: Hu, Xi’e, et al.
Publicado: (2021)